Open Label Study of Single Agent Oral RG7388 in Patients With Polycythemia Vera and Essential Thrombocythemia

NCT02407080 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

OTHER

Sponsor class

Conditions

Polycythemia Vera
Essential Thrombocythemia

Interventions

DRUG: RG7388
DRUG: Pegasys

Sponsor

John Mascarenhas

Collaborators

[object Object]
[object Object]